Escalated complement activation during hospitalization is associated with higher risk of 60-day mortality in SARS-CoV-2-infected patients.
Barratt-Due A, Pettersen K, Børresdatter-Dahl T, Holter JC, Grønli RH, Dyrhol-Riise AM, Lerum TV, Holten AR, Tonby K, Trøseid M, Skjønsberg OH, Granerud BK, Heggelund L, Kildal AB, Schjalm C, Aaløkken TM, Aukrust P, Ueland T, Mollnes TE, Halvorsen B; NOR‐Solidarity study groupThe Norwegian SARS‐CoV‐2 study group.
Barratt-Due A, et al. Among authors: mollnes te.
J Intern Med. 2024 Mar 27. doi: 10.1111/joim.13783. Online ahead of print.
J Intern Med. 2024.
PMID: 38539241